Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (ABVX)
CUSIP: 00370M103
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Ordinary Shares, nominal value Euro 0.01 per share
- Shares outstanding
- 78,459,900
- Total 13F shares
- 30,664,346
- Share change
- -1,096,424
- Total reported value
- $234,581,803
- Price per share
- $7.65
- Number of holders
- 43
- Value change
- -$5,694,979
- Number of buys
- 22
- Number of sells
- 19
Quarterly Holders Quick Answers
What is CUSIP 00370M103?
CUSIP 00370M103 identifies ABVX - Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00370M103:
Top shareholders of ABVX - Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TCG Crossover Management, LLC |
13F
|
Company |
7.7%
|
6,056,596
|
$37,853,725 | — | 31 Mar 2025 | |
| Deep Track Capital, LP |
13D/G
13F
|
Company |
4.8%
|
3,480,144
|
$28,885,195 | $0 | 30 Jun 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
2.8%
|
2,210,019
|
$13,812,619 | — | 31 Mar 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.7%
|
2,130,000
|
$13,312,500 | — | 31 Mar 2025 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
2.1%
|
1,638,111
|
$10,238,194 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.9%
|
1,482,994
|
$9,268,713 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.8%
|
1,373,860
|
$8,586,626 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.7%
|
1,371,050
|
$8,569,063 | — | 31 Mar 2025 | |
| VR Adviser, LLC |
13F
|
Company |
1.7%
|
1,345,780
|
$8,411,125 | — | 31 Mar 2025 | |
| Caligan Partners LP |
13F
|
Company |
1.6%
|
1,269,119
|
$7,931,994 | — | 31 Mar 2025 | |
| Octagon Capital Advisors LP |
13F
|
Company |
1.6%
|
1,230,000
|
$7,687,500 | — | 31 Mar 2025 | |
| Allostery Investments LP |
13F
|
Company |
1.4%
|
1,099,654
|
$6,872,838 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
987,414
|
$6,171,338 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.2%
|
907,679
|
$5,672,994 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.91%
|
710,516
|
$4,440,725 | — | 31 Mar 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.73%
|
570,668
|
$3,566,675 | — | 31 Mar 2025 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.7%
|
552,926
|
$3,455,788 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.63%
|
497,153
|
$3,107,206 | — | 31 Mar 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.58%
|
455,684
|
$2,848,025 | — | 31 Mar 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.54%
|
425,000
|
$2,656,250 | — | 31 Mar 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.29%
|
225,191
|
$1,407,444 | — | 31 Mar 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.28%
|
220,845
|
$1,380,281 | — | 31 Mar 2025 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
210,901
|
$1,318,131 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.26%
|
201,924
|
$1,262,025 | — | 31 Mar 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.25%
|
200,000
|
$1,250,000 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.23%
|
184,239
|
$1,151,494 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.21%
|
162,554
|
$1,015,963 | — | 31 Mar 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.16%
|
125,000
|
$781,250 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.1%
|
74,841
|
$467,758 | — | 31 Mar 2025 | |
| Shay Capital LLC |
13F
|
Company |
0.07%
|
52,829
|
$330,181 | — | 31 Mar 2025 | |
| HighVista Strategies LLC |
13F
|
Company |
0.06%
|
49,064
|
$306,650 | — | 31 Mar 2025 | |
| Paloma Partners Management Co |
13F
|
Company |
0.05%
|
38,449
|
$240,306 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.04%
|
29,418
|
$183,863 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.02%
|
19,000
|
$118,750 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
16,749
|
$104,681 | — | 31 Mar 2025 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.02%
|
13,792
|
$86,200 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
11,446
|
$71,538 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
10,706
|
$66,913 | — | 31 Mar 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
10,152
|
$63,450 | — | 31 Mar 2025 | |
| Hurley Capital, LLC |
13F
|
Company |
0%
|
3,015
|
$18,844 | — | 31 Mar 2025 | |
| GAMMA Investing LLC |
13F
|
Company |
0%
|
3,013
|
$18,831 | — | 31 Mar 2025 | |
| Covestor Ltd |
13F
|
Company |
0%
|
2,660
|
$17,000 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
1,478
|
$9,238 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
738
|
$4,610 | — | 31 Mar 2025 | |
| Financial Management Professionals, Inc. |
13F
|
Company |
0%
|
100
|
$625 | — | 31 Mar 2025 | |
| PRINCIPAL SECURITIES, INC. |
13F
|
Company |
0%
|
10
|
$73 | — | 31 Mar 2025 |
Institutional Holders of Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (ABVX) as of Q2 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.